Table 1 Characteristics and baseline demographics of the patients in each included study
| Author (published year) | Study design (country) | Study period | Median follow-up period (months) | No. of pts | Gender (M/F) | Ages (years) | Etiology (HBV/others) | AFP (ng/ml) | Resection type (minor/major) | Tumor (S/M) | Tumor size (cm) | CP (A/B) | Cirrhosis (N/Y) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| mGVI cohorts | |||||||||||||
| Shi J, et al. (2010) [15] | RC (China) | 2001–2003 | 6.4 (3–72) | 139 | 123/16 | 48.3 ± 9.7 | 131/8 | 635.2 ± 436.3 | 38/91 | 14/10 | 16/123 (< 5/ ≥ 5) | 134/5 | 28/111 |
| Yamamoto Y, et al. (2015) [24] | RC (Japan) | 1980–2009 | 50.3 | 73 | 67/6 | 60.1 ± 9.7 | NA | 9006 ± 34,819 | NA | 41/32 | 5.47 ± 3.38 | NA | NA |
| Park YK, et al. (2017) [25] | RC (Korea) | 1994–2012 | 40 (1–204) | 103 | 85/18 | 51.4 ± 10.5 | 83/20 | 7336.6 ± 16,371.8 | 46/57 | 76/27 | 7.2 ± 3.7 | 94/8 | 47/46 |
| Reference cohort | |||||||||||||
| Cucchetti A, et al. (2020) [26] | RC (6 centers) | 1990–2015 | NA | 2,523 | 2,063/460 | median (IQR), 60 (50–68) | 1,394/1,129 | median (IQR), 21.5 (5.6–300) | NA | 1,948/575 | median (IQR), 4.0 (2.5–6.2) | 2,414/109 | NA |